1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INNATE PHARMA - ADR

Innate Pharma - ADR

XNAS: IPHA

Download real time

1.88 0.06 (3.30%)

46.44% Fall from 52W High

57,887 XNAS Volume

High volume today

XNAS 11 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
157.6

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

14.6

Price to Book

High in industry
0.4

Beta 1Year

Very Low volatility
Board Meeting
The board meeting for Innate Pharma - ADR is scheduled for today, for the purpose of Innate Pharma SA Annual Report for 2024 See details

Innate Pharma - ADR - IPHA - stock price prediction, stock price target, analyst ratings from 3 analysts

Innate Pharma - ADR has a share price target of US$ 8, revenue growth forecast of 435.4%, and profit growth estimate of 151.4% for FY25, based on top 3 analyst calls.

Forecaster Screeners